ArticleDiabetes, obesity & metabolism2023

Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study.

Konstantinos Stefanakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.